Submissions open:

6 November 2024

Deadline:

20 May 2025

Professor Xianting Ding                                                        Professor Kelong Fan

(Shanghai Jiao Tong University, Shanghai)                 (Institute of Biophysics of CAS, Beijing)

Professor Wenpei Fan                                                           Professor Meng Zheng

(China Pharmaceutical University, Nanjing)                (Henan University, Kaifeng)

The intersection of immunology and nanotechnology indeed represents a significant frontier in biomedical research and clinical applications. Nanomaterials possess unique physicochemical characteristics that enable them to interact with the immune system in ways that bulk materials cannot. Their small size, high surface area to volume ratio, and tunable surface properties allow them to evade immune detection and modulate immunological responses. The application of nanomaterials to immunology can provide a deeper understanding of how immune mechanisms work and how they can be manipulated to improve the immune response. This Special Issue highlights recent trends of nanomaterials in immune modulation, diagnostics, and therapy. Furthermore, it discusses the nanotoxicology and biocompatibility challenges associated with immunoregulatory nanomaterials, and their potential in clinical applications.

This Special Issue in Nano Biomedicine and Engineering (NBE) aims to provide a platform to showcase the recent progress and challenges in the field of immunoregulatory nanomaterials. The scope of the collection is broad, including but not limited to

• The interactions between nanomaterials and the immune system, including immune cell activation, inflammation, immunosuppression, tissue regeneration process, etc.
• Nanomaterials in immunodiagnosis, including the use of immunoregulatory nanoparticles in biosensors for early and accurate detection of diseases.
• Nanomaterials in vaccine development, including the synthesis and functionalization of lipid NPs, polymeric NPs, and other nanocarriers that can be used to create vaccines against different diseases.
• Targeted drug delivery systems for treating autoimmune diseases and cancer.
• Biocompatibility and nanotoxicology of immunoregulatory nanomaterials.

We hope that readers find this Special Issue informative and useful for the rational design, construction and further clinical translation of immunoregulatory nanomaterials. This call for papers is open for the following article types:

• Research Article
• Review

Open for submission until 20 May 2025

If you would like to contribute to this Special Issue, you can submit your article directly through the NBE online submission service. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of both the journal and the collection, and the inclusion of accepted articles in the Special Issue is not guaranteed. Please also note that all submissions will undergo our normal rigorous peer review processes.

Editorial Office

For any questions, please feel free to contact us:

Add: No. 1954 Huashan Road, Xuhui District, Shanghai, China (200030)

Tel: +86-21-62800087

E-mail: zhangpk@sjtu.edu.cn

NBE Editorial Office

6 November 2024